AIForceTech is a company that specializes in agricultural robotics. It is also accelerating the launch of new energy agricultural machinery, including unmanned pure electric tractors and a variety of electric-powered agricultural robot products. These products are currently being used in real-world scenarios and have gained valuable experience. AIForceTech was founded in 2019 and is headquartered in Beijing's Haidian District.
Yuneng Technology specializes in the development of advanced soft magnetic materials, primarily aimed at enhancing battery performance and wireless charging efficiency. The company focuses on creating nanocrystalline material formulas and employs innovative magnetic isolation sheet process technology. These advancements are designed to improve charging power and overall efficiency in wireless charging products. Yuneng Technology serves a diverse range of clients across various sectors, including consumer electronics, new energy vehicles, and the photovoltaic industry, providing them with high-performance magnetic materials that meet the demands of modern applications.
Yuntian Semiconductor is a semiconductor firm that develops TGV technology, filter wafer-level 3-D packaging technology, and IPD technology.
Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.
Juventas is a developer of innovative immune cell therapeutic drugs aimed at treating malignant hematological neoplasms, including leukemia and lymphoma. The company has had its first investigational new drug application for the cell therapeutic product CNCT19 accepted by the National Medical Products Administration. Juventas is committed to developing a comprehensive product pipeline that focuses on advancing immune cell therapies and accelerating innovation in this field, thereby providing effective treatment options for patients suffering from these serious conditions.
AIForceTech is a company that specializes in agricultural robotics. It is also accelerating the launch of new energy agricultural machinery, including unmanned pure electric tractors and a variety of electric-powered agricultural robot products. These products are currently being used in real-world scenarios and have gained valuable experience. AIForceTech was founded in 2019 and is headquartered in Beijing's Haidian District.
Developer and provider of computing software solutions focused on autonomous driving. The company's software provides full-stack autonomous driving solutions that integrates software development and hardware design, providing consumers with a safe and efficient autonomous transportation method.
Developer of a protocol-agnostic liquidity protocol designed to optimize yield. The company's platform uses different data points and techniques to attain the optimum value and return on investments, understands the circumstances of a liquidity provider's supply event and the discovery algorithm takes in the latest gas costs, asset volatility, the past and present yield and budget of the asset supplied, enabling users to get optimum yield from asset allocation across Defi protocols.
Zhishan Weixin Biotechnology
Series A in 2021
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
Shanghai Polaris Biology Co., Ltd. is a medical technology company focused on developing a cell diagnostic technology platform for tumors. Established in 2016 and based in Shanghai, China, the company utilizes artificial intelligence-based cell analysis models to examine dynamic changes in tumors at the cellular level. This innovative approach aims to enhance clinical tumor diagnosis and treatment by providing precise and accurate diagnostic tools for both patients and healthcare professionals. Polaris Biology is dedicated to advancing the understanding of individual tumor characteristics, thereby supporting more effective clinical decision-making in cancer care.
Sophonix Co., Ltd. is a company that specializes in the manufacturing of in vitro diagnostic equipment and reagents. Founded in 2017 and headquartered in Beijing, China, with an additional office in California, the company offers a range of products including automatic chemiluminescence immune analyzers, automatic immunohistochemical staining apparatus, and chemiluminescence immunoassay reagents. Sophonix is dedicated to developing and selling accurate point-of-care testing (POCT) solutions, contributing to advancements in pathological and immunodiagnostic practices.
YEESTOR Microelectronics Co., Ltd specializes in the development and sale of memory control chips, focusing primarily on storage controllers. Established in 2007 and headquartered in Shenzhen, China, the company provides a range of products including PCIe SSD controllers, SATA SSD controllers, UFS controllers, eMMC controllers, USB controllers, and security storage controllers. These products are used across various applications, such as data centers, servers, personal computers, smartphones, tablets, smart homes, and the Internet of Things. YEESTOR serves clients that include storage IC companies and module manufacturers, offering technical support and customized solutions to enhance design efficiency and reliability. The company emerged from the merger of SiliconGo Microelectronics and Auspitek and has achieved significant milestones, including cumulative shipments exceeding 700 million units, positioning itself as a leading global supplier in the flash memory controller market.
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing novel protein and peptide therapeutics for cancer treatment. The company specializes in creating prodrugs that utilize innovative platforms such as XTEN for half-life extension, XPAT for protease-activated T cell engagement, and ProTIA for immuno-oncology applications. Amunix aims to develop therapies that can effectively activate the immune system to target solid tumors, thereby improving patient outcomes. The company collaborates with various partners in the biotechnology and pharmaceutical sectors to leverage its proprietary technologies across multiple therapeutic areas. Founded in 2006 and headquartered in Mountain View, California, Amunix is committed to advancing breakthrough therapies to combat cancer.
Hummingbird Bioscience Pte. Ltd. is a biotechnology company based in Singapore, specializing in the development of antibody-based therapeutics for cancer. Founded in 2014, it leverages advances in systems biology and a proprietary rational antibody discovery platform to create innovative biotherapeutics. The company focuses on a diverse pipeline of drug candidates, which includes lead assets such as HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, both aimed at addressing significant unmet medical needs in oncology. Hummingbird Bioscience has established strategic collaborations with notable organizations such as Cancer Research UK and Amgen, and it has received a product development grant from the Cancer Prevention and Research Institute of Texas. The company's goal is to enhance treatment options for patients facing challenging cancer diagnoses through its cutting-edge research and development efforts.
SeekGene specializes in genetic data analysis solutions, particularly in the development and clinical application of single-cell sorting assays. The company leverages its extensive research and clinical service experience to advance single-cell sequencing technology for real-world clinical research. SeekGene has developed a high-throughput single-cell transcriptome sequencing kit that is recognized for its superior performance, flexibility, and cost-effectiveness. This technology aims to facilitate the clinical transformation of single-cell sequencing, enabling better understanding of immune responses at the single-cell level. Additionally, SeekGene focuses on T cell receptor and peptide-bound major histocompatibility complex pairing technologies, which are essential for clinical and drug research, as well as for monitoring and treating various diseases.
HiFiBiO is a biotherapeutics company focused on harnessing the human immune system to address diseases, particularly cancer and autoimmune disorders. Founded in 2013 and based in Paris, the company specializes in proprietary single-cell technologies that facilitate drug and biomarker discovery and development. HiFiBiO's platform combines extensive biological knowledge with advanced single-cell profiling techniques, allowing for the rapid identification and advancement of antibody drugs. Through partnerships with both industry and academic institutions, HiFiBiO aims to promote open innovation and enhance patient outcomes by unlocking the therapeutic potential of the immune system.
LEMON Photonics Technologies Co. Ltd. is a high-tech company based in Shenzhen, China, established in 2018 by a team of experienced professionals in the laser industry. The company specializes in the research, development, sale, and industrialization of semiconductor electro-optical devices, modules, and systems. LEMON offers a range of products, including low-power direct diode lasers, fiber-coupled diode lasers, and high-power direct diode lasers, catering to various industrial applications.
Beijing Rinfon Technology Co., Ltd. specializes in the research, development, and production of wireless communication systems tailored for unmanned platforms, including satellites and drones. The company offers a range of products, such as wideband signal and interference generators, measurement and control transponder simulators, jump spread spectrum testers, and wideband signal recording players. Rinfon is recognized as a leading provider of satellite signal solutions and modules, contributing innovative communication products and comprehensive test solutions for the aerospace and drone industries. Based in Beijing, China, Rinfon focuses on enhancing the capabilities of satellite and UAV communications through advanced technology and dedicated service.
Panorama Medicine, Inc. is a pharmaceutical company based in Philadelphia, Pennsylvania, focused on developing a drug discovery platform that addresses RNA defects associated with various diseases. Founded in 2018, the company utilizes an integrated approach that combines genomics, big data, and advanced computing techniques to produce and analyze data for therapeutic interventions. This platform aims to enhance the detection of RNA-related issues within medical conditions, facilitating the validation of discoveries and supporting medical companies in their research and development efforts.
Archiwave Micro
Series A in 2019
Anqiwei Microelectronics was incorporated in July 2015 to focus on the development of high-performance RF microwave integrated circuits and module products based on silicon germanium SiGe BiCMOS, silicon-on-insulator SOI-CMOS and bulk silicon CMOS processes. Dr. Lu Jianhua, the founder of the company, received his Ph.D. from the University of California, Los Angeles (UCLA) and has been involved in RF and microwave integrated circuit design and product development in California. His products have won the ECN Impact Award. And Microwave Journal Best Product, and published the IEEE JSSC paper and several US patents as the first author. Several other core co-founders are top RF RF chip and system experts in the country and have accumulated decades of industry experience.
DFocus is a Shanghai-based company founded in 2015 that specializes in cloud-based software for workspace planning and management. The company pioneers smart connected space solutions, utilizing Internet of Things (IoT) technology, high-precision sensors, and big data analysis to enhance workspace utilization and reduce costs for enterprises. DFocus's offerings include wireless occupancy sensors and sensor networks that allow organizations to collect and analyze data through a cloud solution. This data-driven approach provides meaningful insights into space utilization, employee wellbeing, and productivity, ultimately aiming to improve the overall work experience. Additionally, DFocus features a real estate asset management platform designed to help organizations optimize their real estate investments and lower operational costs.
Majorsec is a provider of advanced security solutions specializing in host intrusion prevention systems (HIPS) and endpoint detection and response (EDR) technology. The company focuses on enhancing users' capabilities to defend against unknown threats, including ransomware, advanced persistent threats (APTs), and Trojan horses. Majorsec's security detection technology aims to bolster the internal security posture of host operating systems, allowing organizations to maintain greater control over their enterprise network's security status. Through its innovative approach, Majorsec enables businesses to secure and protect their digital environments effectively.
DBSec is an Enterprise services company.
OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases. Its portfolio includes ONK102, an inhibitor that reduces the growth rate of tumors in hematological and solid tumor cancers. OnKure, Inc. was incorporated in 2011 and is based in Boulder, Colorado.
EcoFlow Technology Ltd. is a company that specializes in portable energy solutions, developing products such as portable charging stations, backup generators, and emergency batteries. Founded in 2016 and headquartered in Shenzhen, China, with an additional office in San Francisco, California, EcoFlow aims to provide mobile power to users both indoors and outdoors. Their products are designed to be versatile, rechargeable through solar, car, or wall chargers, and incorporate features that enhance safety and efficiency, such as temperature regulation and individual output port management. EcoFlow's mission extends beyond convenience, as it seeks to improve living standards in regions facing power shortages, thereby promoting economic growth and development. The company markets its products through online platforms and retail stores, contributing to a more sustainable and accessible energy future.
Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.
MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available in China. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
12 Sigma Technologies, founded in April 2015, is a healthcare company that focuses on modern medical image diagnosis and data analysis. The firm leverages advanced artificial intelligence technologies to enhance medical imaging applications, believing in the significant potential of integrating AI with medical imaging. To further its mission, 12 Sigma has established partnerships with General Electric to co-develop innovative diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, the company collaborates with over 50 leading hospitals in China, engaging in applied medical diagnostics, technical research, and clinical trials to advance its healthcare solutions.
Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.
Provider of aerial vehicles designed for the drone industry. The company offers a range of drones, helicopters and other products capable of short-term flight which can be propelled via remote control, providing engineers and drone enthusiasts with robotic drones that have a variety of applications ranging from structure inspection to defense and surveillance.